Bizarre Patents
An electrified table cloth for preventing crawling insects from gaining access to the consumer's food or drink.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8084070 | Isomalt in cereal products The present invention relates to cereal products comprising cereals and a mixture of 1,6-GPS and 1,1-GPM, methods for the production thereof and the use of a mixture comprising 1,6-GPS and 1,1-GPM for producing cereal products. ... | 12/27/2011 |
| 7547446 | Dry hemostatic compositions and methods for their preparation Dry cross-linked gelatin compositions are prepared that rapidly re-hydrate to produce gelatin hydrogels suitable as hemostatic sealants. Gelatin is cross-linked in the presence of certain re-hydration aids, such as polyethylene glycol, polyvinylprovidone, and dextra... | 06/16/2009 |
| 7455857 | Energy generating composition The present invention is drawn to an ephedra- and artificial stimulant-free energy promoting composition, comprising effective amounts of a magnesium amino acid chelate, a B vitamin, a pyruvate salt, and rhodiola. These ingredients work synergistically together to p... | 11/25/2008 |
| 7445796 | Pharmaceutically active particles of a monomodal particle size distribution and method A method of obtaining improved reproducibility of dissolution profiles of dosage forms containing pharmaceutically active particles includes steps of screening raw pharmaceutically active particles to obtain or isolate particles having a desired monomodal particle s... | 11/04/2008 |
| 7442402 | Bioactive agent release coating A coating composition for use in coating implantable medical devices to improve their ability to release bioactive agents in vivo. The coating composition is particularly adapted for use with devices that undergo significant flexion and/or expansion in the course of... | 10/28/2008 |
| 7438925 | Drug eluting coatings for medical implants Drug eluting coating compositions are composed of at least one therapeutic agent dispersed in modified, biologically active binders. The therapeutic agents included in the coating composition are paclitaxel, sirolimus, tacrolimus, everolimus, actinomycin-D, dexameth... | 10/21/2008 |
| 7438927 | Methods of treatment using a gastric retained gabapentin dosage A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form. ... | 10/21/2008 |
| 7435426 | Micron sized bicarbonate particles and slurrys containing the same This invention provides substantially spherical, micron and submicron sized alkali metal bicarbonate particles. When combined with a liquid medium, the alkali metal bicarbonate particles have an exceptional capability to form a flowable slurry which demonstrates lon... | 10/14/2008 |
| 7435425 | Dry hemostatic compositions and methods for their preparation Dry cross-linked gelatin compositions are prepared that rapidly re-hydrate to produce gelatin hydrogels suitable as hemostatic sealants. Gelatin is cross-linked in the presence of certain re-hydration aids, such as polyethylene glycol, polyvinylprovidone, and dextra... | 10/14/2008 |
| 7431944 | Delivery of multiple doses of medications Dosage forms for oral administration of a methylphenidate drug are provided. The dosage forms provide a substantially immediate dose of methylphenidate upon ingestion, followed by one or more additional doses at predetermined times. By providing such a drug release ... | 10/07/2008 |
| 7431943 | Controlled release and taste masking oral pharmaceutical compositions Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrop... | 10/07/2008 |
| 7427409 | Broad spectrum antimicrobial purification materials and methods for purifying fluids Purification materials with broad spectrum antimicrobial properties and methods and devices for fluid treatment utilizing said materials are provided. The purification materials include biguanide hydrates and bases. A particular composition includes chlorhexidine di... | 09/23/2008 |
| 7419684 | System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same A system and method for manufacturing oral osmotic drug delivery devices including the use of a mathematical model in deriving relationships between parameters used in manufacturing the devices for a desired release rate of the active drug substance contained therei... | 09/02/2008 |
| 7413751 | Methods of treatment using a gastric retained losartan dosage A method of treatment for hypertension and other disease states is described, which comprises the delivery of losartan in a gastric retained dosage form. ... | 08/19/2008 |
| 7410652 | Controlled release and taste masking oral pharmaceutical composition Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrop... | 08/12/2008 |
| 7410651 | Controlled release and taste masking oral pharmaceutical composition Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrop... | 08/12/2008 |
| 7402321 | Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release c... | 07/22/2008 |
| 7396542 | Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof Provided are formulations of a stable commercial paroxetine tablet comprising paroxetine hydrochloride anhydrous, povidone, copovidone or HPMC as a binder, and an HCl free/non-hygroscopic filler, prepared by the wet granulation method. ... | 07/08/2008 |
| 7390503 | Ondansetron orally disintegrating tablets An ondansetron solid orally disintegrating dosage form for oral administration having at least one first water-dispersible component or water-insoluble cellulose derivative, a component having a —CHOH functional group, a disintegrating agent and at least one lubri... | 06/24/2008 |
| 7387794 | Preparation of powder agglomerate The invention relates to a method of producing an agglomerate of drug and solid binder. The process involves producing individual agglomerate particles and then converting the convertible amorphous content of same, following agglomeration, by the application of, for... | 06/17/2008 |
| 7374772 | Topical antifungal treatment The present invention is a topical skin preparation for treatment of fungal infections of the skin and nails. The preparation comprises triacetin in combination with an antifungal agent. In a preferred form, the preparation further comprises, a fatty acid source suc... | 05/20/2008 |
| 7357945 | Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof Provided are formulations of a stable paroxetine hydrochloride tablet comprising paroxetine hydrochloride, povidone or copovidone as a binder, and an HCl free/non-hygroscopic filler, prepared by the wet granulation method. Preferably, the paroxetine hydrochloride is... | 04/15/2008 |
| 7348028 | Chronotherapeutic diltiazem formulations and the administration thereof A method of treating or preventing myocardial ischemia in a patient in need thereof comprising administration of a controlled-release Galenical preparation of pharmaceutically acceptable Diltiazem including the pharmaceutically acceptable salts thereof, suitable for... | 03/25/2008 |
| 7344734 | Powder formulation The invention relates to a powder formulation for administration by inhalation comprising an active substance and a pharmaceutically acceptable excipient, which composition has the form of a physical mixture and comprises from 5 to 25 wt. % of the excipient, and whe... | 03/18/2008 |
| 7318934 | Method for treating wounds to promote healing A method of treating a mammal to promote wound healing in the mammal in need thereof, comprising orally administering to the mammal an effective amount of a palatable, concentrated protein composition comprising an effective amount of hydrolyzed gelatin and tryptoph... | 01/15/2008 |
| 7311925 | Methods and compositions for blocking microbial adherence to eukaryotic cells A method of blocking microbial adherence to a eukaryotic cell surface in a mammal by applying a pharmacologically acceptable composition containing at least one compound selected from the group consisting of isoleucine, an active isomer thereof, and an active analog... | 12/25/2007 |
| 7311927 | Antiseptic solutions containing silver chelated with polypectate and EDTA A liquid antiseptic and cleanser having improved long-term stability includes at least the following principal ingredients: deionized water; silver ion, polypectate, and ethylenediaminetetraaceticacid (EDTA). Presently preferred embodiments of the technology also in... | 12/25/2007 |
| 7309499 | Fish gelatin hard capsule and its preparation method The object of the present invention is to provide a process for preparing fish gelatin capsule comprising the steps of; i) preparing a mixed solution of pectin and glycerin; ii) adding said mixed solution to solubilized fish gelatin solution; iii) adding a small amo... | 12/18/2007 |
| 7309497 | Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients The invention relates to novel pharmaceutical compositions for the systemic administration of pharmacologically active ingredients. The invention relates in particular to an injectable pharmaceutical composition comprising (a) a pharmacologically active ingredient i... | 12/18/2007 |
| 7306109 | System and method of administering pharmaceuticals and nutraceuticals as part of a beverage container A system and method for providing a dry consumable with a liquid in the same assembly. The assembly includes a fluid container that is covered with a cap assembly. The cap assembly can be manually opened and closed, thereby selectively controlling the flow of fluid ... | 12/11/2007 |
| 7303763 | Compositions for conjugated estrogens and associated methods Oral conjugated estrogen formulations are disclosed and described. In one aspect, the oral formulation may be a tablet having a core and one or more coatings thereon. In addition to conjugated estrogen ingredients, the core may include one or more organic excipients... | 12/04/2007 |
| 7282221 | Antiviral product, use and formulation thereof An antiviral product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antiviral product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosag... | 10/16/2007 |
| 7273621 | Compositions for promoting sleep An object of the present invention is to provide a composition for promoting sleep, which any one can safely take on a daily basis without any risks of adverse action. In addition, an object of the present invention is to provide food and a medicament, comprising th... | 09/25/2007 |
| 7258851 | Cholesterol reducing chewing gum composition and method of making the same Center fill chewing gum compositions containing an effective amount of at least one stanol compound sufficient to provide a positive cholesterol effect in a warm-blooded animal including humans. ... | 08/21/2007 |
| 7252835 | Agent for preventing and/or treating sinusitis An agent for preventing and/or treating sinusitis, comprising, as an active ingredient, a compound of the formula (I): or a salt and/or hydrate thereof. The pranlukast hydrate is useful as an agent for pr... | 08/07/2007 |
| 7250174 | Cosmetic, personal care, cleaning agent, and nutritional supplement compositions and methods of making and using same The present invention involves new cosmetic, personal care, cleaning agent, biocidal agent, functional food, and nutritional supplement compositions. These new compositions incorporate bioactive glass into cosmetics, personal care items, cleaning agents, biocidal ag... | 07/31/2007 |
| 7244451 | Methods of making nanoparticulate drug compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers The present invention is directed to nanoparticulate compositions comprising a poorly soluble drug and at least one copolymer of vinyl pyrrolidone and vinyl acetate as a surface stabilizer adsorbed to the surface of the drug. Also encompassed by the invention are ph... | 07/17/2007 |
| 7244439 | Cosmetic composition A cosmetic composition having excellent application feeling and transparency while maintaining covering power which includes (a) composite particles obtained by allowing at least two kinds of particles having different shapes and particle diameters to contact with a... | 07/17/2007 |
| 7238355 | Coated material and process for producing the coated material A coated material and a process for producing the coated material which includes providing a coating agent comprising yeast cell wall fractions, as a primary constituent, consisting of cell residue of yeast which has been treated with enzymes, optionally subsequentl... | 07/03/2007 |
| 7238370 | Method and composition to prevent and treat photoaging of skin A method and composition for stimulating skin function to prevent and reverse the effects of photoaging, without removal of the protective stratum corneum. The composition of the invention is a mixture of coarse pumice and an aqueous surfactant emulsion. ... | 07/03/2007 |
